Role of mesoporous silicates on carbamazepine dissolution rate enhancement

[1]  C Rossi,et al.  Improvement of dissolution rate of piroxicam by inclusion into MCM-41 mesoporous silicate. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[2]  F. Marmottini,et al.  Effect of MCM-41 on the dissolution rate of the poorly soluble plant growth regulator, the indole-3-butyric acid , 2006 .

[3]  M. B. James,et al.  The influence of thermal and mechanical preparative techniques on the amorphous state of four poorly soluble compounds. , 2005, Journal of pharmaceutical sciences.

[4]  J. Yates,et al.  Structural Studies of the Polymorphs of Carbamazepine, Its Dihydrate, and Two Solvates , 2005 .

[5]  M. Snowden,et al.  Effect of SBE7-beta-cyclodextrin complexation on carbamazepine release from sustained release beads. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[6]  Jennifer B Dressman,et al.  Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[7]  Gion Calzaferri,et al.  Molecular sieves as host materials for supramolecular organization , 2004 .

[8]  Paulo Mayorga,et al.  Bioavailability of carbamazepine:beta-cyclodextrin complex in beagle dogs from hydroxypropylmethylcellulose matrix tablets. , 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[9]  A. Matzger,et al.  Comparison of the four anhydrous polymorphs of carbamazepine and the crystal structure of form I. , 2003, Journal of pharmaceutical sciences.

[10]  Yun Peng,et al.  Generalization of a prototype intelligent hybrid system for hard gelatin capsule formulation development , 2002, AAPS PharmSciTech.

[11]  J. Choma,et al.  CRITICAL APPRAISAL OF CLASSICAL METHODS FOR DETERMINATION OF MESOPORE SIZE DISTRIBUTIONS OF MCM-41 MATERIALS , 2002 .

[12]  K. Gubbins,et al.  Freezing behavior in porous glasses and MCM-41 , 2001 .

[13]  P. Arnaud,et al.  In vitro and in vivo evaluation of carbamazepine-PEG 6000 solid dispersions. , 2001, International journal of pharmaceutics.

[14]  C. Rustichelli,et al.  Solid-state study of polymorphic drugs: carbamazepine. , 2000, Journal of pharmaceutical and biomedical analysis.

[15]  R. Löbenberg,et al.  Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[16]  D. Voinovich,et al.  Formulation and Evaluation of Vinylpyrrolidone/Vinylacetate Copolymer Microspheres with Carbamazepine , 2000, Pharmaceutical development and technology.

[17]  M. Otsuka,et al.  Effect of environmental humidity on the transformation pathway of carbamazepine polymorphic modifications during grinding , 1999 .

[18]  A. Zukal,et al.  Controlling of morphology and characterization of pore structure of ordered mesoporous silicas , 1999 .

[19]  F. Schüth,et al.  Ordered mesoporous materials , 1999 .

[20]  M. Friedman,et al.  Crystalline properties of carbamazepine in sustained release hydrophilic matrix tablets based on hydroxypropyl methylcellulose. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[21]  J. B. Higgins,et al.  A new family of mesoporous molecular sieves prepared with liquid crystal templates , 1992 .

[22]  E. Teller,et al.  ADSORPTION OF GASES IN MULTIMOLECULAR LAYERS , 1938 .

[23]  U. Wenzel,et al.  Zum kristallografischen Verhalten des Carbamazepins unter Pressdruck , 1987 .

[24]  F. Krahn,et al.  Relations between several polymorphic forms and the dihydrate of carbamazepine. , 1987, Pharmaceutica acta Helvetiae.

[25]  J. Guyot,et al.  Polymorphic Transitions of Carbamazepine During Grinding and Compression , 1986 .

[26]  M. Attia,et al.  Dissolution Rates of Carbamazepine and Nitrazepam Utilizing Sugar Solid Dispersion System , 1985 .